Peptide dosing guides

NNMT inhibitor for enhanced fat metabolism and NAD+ preservation

Cycle 8-12 weeks

ActRIIB-Fc fusion protein for muscle mass - blocks myostatin pathway

Cycle 8-12 weeks

Adrenocorticotropic hormone that stimulates the adrenal cortex to secrete cortisol and other glucocorticoids. Secretion follows circadian rhythm and increases with stress. Used diagnostically as cosyntropin.

Cycle Per medical plan

Adamax is an adamantane-modified analog of Semax (N-acetyl Semax Amidate), a heptapeptide derivative of ACTH(4–10) studied for nootropic and neuroprotective properties. The adamantane moiety enhances blood–brain barrier penetration and peptide stability, yielding greater potency than standard Semax.

Cycle 4-8 weeks

Pro-apoptotic peptidomimetic that targets blood vessels of white adipose tissue. Caused rapid weight loss and improved insulin resistance in obese monkeys but produced mild reversible renal injury.

Cycle Investigational

AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is a research compound that activates AMP-activated protein kinase (AMPK), earning the nickname 'exercise pill' after studies showed sedentary animals given AICAR experienced dramatic endurance improvements.

Cycle 2-4 weeks

Comprehensive longevity stack for cellular rejuvenation

Cycle Epitalon cycles 2-3x/year, others ongoing

Modified HGH fragment 176-191 for fat metabolism without GH side effects. AOD-9604 is a modified form of amino acids 176-191 of the human growth hormone polypeptide. It stimulates lipolysis and inhibits lipogenesis, promoting fat burning without affecting blood sugar or growth.

Cycle 12 weeks typical

This synergistic blend combines three peptides targeting body composition: AOD-9604 (hGH fragment 177-191) promotes lipolysis without raising IGF-1; CJC-1295 (GHRH analog) produces sustained GH and IGF-1 elevations; and Ipamorelin (ghrelin mimetic) selectively stimulates GH secretion without increasing cortisol or ACTH.

Cycle 8-12 weeks

ARA-290 (cibinetide) is an 11-amino acid non-erythropoietic peptide derived from erythropoietin's helix-B domain. It selectively activates the innate repair receptor (IRR), an EPOR/CD131 heterodimer, to promote anti-inflammatory and tissue-protective effects without stimulating red blood cell production.

Cycle 4-12 weeks

Complete recovery and performance optimization for athletes

Cycle Ongoing with periodic breaks

Single-chain analog of human relaxin-2 B-chain that retains antifibrotic, vasodilatory, and cardioprotective effects with minimal cAMP signaling. Easier to produce than native relaxin.

Cycle Investigational

Entry-level GH plan with minimal side effects

Cycle 12-16 weeks

Body Protection Compound-157 is a 15-amino acid peptide derived from human gastric juice. It exhibits remarkable regenerative properties for tendons, ligaments, muscles, and the gastrointestinal tract. BPC-157 promotes angiogenesis, modulates growth factors, and accelerates the healing of various tissues.

Cycle 4-12 weeks

A regenerative blend combining BPC-157's systemic healing with GHK-Cu's tissue remodeling and anti-aging properties. GHK-Cu (copper peptide) promotes collagen synthesis, wound healing, and has potent anti-aging effects on skin and tissues.

Cycle 4-12 weeks

A powerful healing blend combining BPC-157 (body protection compound) and TB-500 (Thymosin Beta-4 fragment). This combination provides synergistic tissue repair, accelerated healing, reduced inflammation, and enhanced recovery for injuries, surgeries, and chronic conditions.

Cycle 4-12 weeks

Arginine salt form of BPC-157 with enhanced stability and potential oral bioavailability

Cycle 4-12 weeks

The ultimate healing combination pairing BPC-157's localized tissue repair with TB-500's systemic healing properties. BPC-157 works at the injury site to accelerate tendon, ligament, and gut healing, while TB-500 promotes whole-body recovery through enhanced cell migration and angiogenesis.

Cycle 4-8 weeks

GLOW is a research peptide blend combining GHK-Cu, TB-500 (Thymosin Beta-4 fragment), and BPC-157 in one 70mg vial. Each component has been studied for its regenerative and healing properties across various tissues. By delivering all three in one formulation, GLOW aims to synergistically promote tissue repair, inflammation reduction, and wound healing beyond what each peptide might achieve alone.

Cycle 4 weeks on, 2-4 weeks off

Cagrilintide is a long-acting acylated analogue of the pancreatic hormone amylin, designed for once-weekly subcutaneous administration. It activates central amylin receptors to promote satiety, slow gastric emptying, and reduce food intake.

Cycle Ongoing

Cagrilintide + Semaglutide is a dual-agonist combination blending an amylin analog (cagrilintide) with a GLP-1 receptor agonist (semaglutide). Clinical trials demonstrate superior weight reduction versus either agent alone, with the combination targeting complementary satiety pathways.

Cycle Ongoing

Combination of a long-acting amylin analog (cagrilintide) and a GLP-1 agonist (semaglutide). Synergistically slows gastric emptying, suppresses glucagon, increases insulin secretion and satiety. Clinical trials showed ~20% weight reduction.

Cycle Chronic

Cardiogen is a synthetic cardiovascular bioregulator tetrapeptide (AEDR: Ala-Glu-Asp-Arg) studied for its cellular repair and cardioprotective properties. It enters cells and modulates fundamental survival pathways, supporting cytoskeletal integrity and reducing apoptosis in stressed cardiac tissue.

Cycle 8-16 weeks

Cartalax is a tripeptide bioregulator (Ala-Glu-Asp) from the Khavinson series that targets cartilage and spinal tissue. It's designed to support cartilage regeneration, spinal health, and musculoskeletal system function through epigenetic regulation.

Cycle 10-20 days, repeat 2-3x yearly

Neurotrophic peptide mixture derived from porcine brain for neuroregeneration and stroke recovery. Cerebrolysin contains multiple neurotrophic factors and has been used clinically in Europe and Asia for decades for stroke, TBI, and dementia.

Cycle 10-20 day cycles, 2-4x per year

Chonluten is a tripeptide bioregulator (Glu-Asp-Gly) from the Khavinson series that specifically targets lung and bronchial tissue. It supports respiratory function, promotes lung tissue regeneration, and protects against age-related decline in pulmonary function.

Cycle 10-20 days, repeat 2-3x yearly

Modified GRF for natural pulsatile GH release pattern - pairs perfectly with GHRPs

Cycle 8-16 weeks, can run indefinitely

Long-acting GHRH analog with Drug Affinity Complex for sustained GH elevation

Cycle 8-16 weeks

CJC-1295 is a long-acting GHRH analog that elevates GH levels 2-10× baseline for approximately 6 days. GHRP-2 is a ghrelin-mimetic secretagogue that triggers rapid GH pulses peaking within ~25 minutes of administration. Combining these leverages GHRP-2's acute pulsatile release with CJC-1295's sustained action.

Cycle 8-12 weeks

The most popular growth hormone secretagogue blend combining CJC-1295 (GHRH analog) and Ipamorelin (GHRP). This combination maximizes GH release by stimulating both the GHRH and ghrelin pathways while maintaining a favorable safety profile with minimal hunger or cortisol increase.

Cycle 8-12 weeks, cycle off 4-8 weeks

The gold standard GH optimization stack combining long-acting CJC-1295 DAC (GHRH) with Ipamorelin (GHRP). This synergistic combination maximizes growth hormone release through complementary pathways: CJC provides sustained GHRH stimulation while Ipamorelin triggers pulsatile release.

Cycle 12-24 weeks

A growth hormone stack combining long-acting CJC-1295 with DAC (Drug Affinity Complex) for sustained GH elevation with daily Ipamorelin pulses. The DAC extends CJC-1295's half-life to 8+ days, allowing weekly dosing while Ipamorelin provides acute GH pulses.

Cycle 8-12 weeks on, 4-8 weeks off

This blend combines CJC-1295 (no DAC), a modified growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue (GHS). CJC-1295 (no DAC) produces sustained, dose-dependent GH and IGF-1 increases, while Ipamorelin selectively stimulates GH release without raising ACTH or cortisol.

Cycle 8-16 weeks

The gold standard GH peptide combination. CJC-1295 (no DAC) is a GHRH that amplifies and extends growth hormone release, while Ipamorelin is the cleanest GHRP that triggers GH pulses. Together they create synergistic, natural pulsatile GH release patterns.

Cycle 8-16 weeks

Comprehensive nootropic stack for focus, memory, and brain health

Cycle 4-6 weeks on, 2 weeks off

A synergistic nootropic stack combining Semax (ACTH derivative for cognition) with Selank (tuftsin derivative for anxiety). Semax enhances focus, memory, and BDNF while Selank provides anxiolytic and mood-stabilizing effects without sedation.

Cycle 4-8 weeks, cycle as needed

Ultimate recovery stack combining healing + GH support

Cycle 8-12 weeks

Cortagen is a tetrapeptide bioregulator (Ala-Glu-Asp-Pro) from the Khavinson series that targets the cerebral cortex and central nervous system. It supports cognitive function, neuroprotection, and brain tissue regeneration through epigenetic modulation.

Cycle 10-20 days, repeat 2-3x yearly

Crystagen is a tripeptide bioregulator (Glu-Asp-Arg) from the Khavinson series that targets the immune system. It supports immune cell function, promotes immune system balance, and helps restore normal immune responses in immunocompromised or aging individuals.

Cycle 10-20 days, repeat 2-3x yearly

DALDA (Dermorphin [D-Arg2, Lys4] analog) is a highly selective delta opioid receptor (DOR) agonist peptide. It's used in pain research and has potential applications in analgesia with reduced addiction potential compared to mu-opioid agonists.

Cycle Research plans only

Amphibian-derived opioid peptide studied for experimental analgesic research. Extremely potent μ-opioid receptor agonist isolated from the skin of South American frogs.

Cycle Short, PRN

Extremely potent cognitive enhancer - 10 million times stronger than BDNF at synaptic repair. Dihexa is an angiotensin IV analog that dramatically enhances synaptic connectivity and memory formation. It was developed for Alzheimer's research.

Cycle 4-6 weeks

Sleep-inducing peptide that enhances delta wave sleep and recovery

Cycle 2-4 weeks on, 2 weeks off

Sleep enhancement combined with telomere/melatonin support

Cycle 2-3 weeks on, then cycle off

Telomerase activator peptide for telomere extension and longevity. Epitalon (AEDG peptide) was developed by Russian scientist Vladimir Khavinson and is the synthetic version of epithalamin, a naturally occurring pineal gland extract. It activates telomerase to lengthen telomeres and regulates melatonin production for improved sleep.

Cycle 10-20 day cycle, 2-3x per year

Telomere support with tissue regeneration for comprehensive anti-aging

Cycle 10-20 day cycles, 2-3x/year

Triple fat-burning peptide stack for stubborn fat

Cycle 12 weeks

Female-optimized stack for recovery, skin, and hormonal balance

Cycle 8-12 weeks

Myostatin inhibitor that blocks the muscle growth limiter

Cycle 10-30 days max

FOXO4-DRI is an innovative senolytic peptide designed to selectively target and eliminate senescent 'zombie' cells. As a D-retro-inverso analog of the FOXO4 protein segment, it disrupts the FOXO4-p53 interaction in senescent cells, freeing p53 to trigger apoptosis and clear dysfunctional cells.

Cycle 2-6 weeks (intermittent)

Dual fat-burning mechanism targeting different pathways

Cycle 12 weeks

TGF-β superfamily growth factor studied for rejuvenation and tissue regeneration. Controversial literature with conflicting results on whether it reverses age-related decline or may have negative effects.

Cycle Investigational

CJC-1295 + Ipamorelin + MK-677 for maximum sustained GH elevation

Cycle 12-24 weeks

Copper-binding tripeptide for skin regeneration, wound healing, and hair growth. GHK-Cu is naturally found in human plasma, saliva, and urine, and declines significantly with age. It regulates over 4,000 genes involved in tissue repair, collagen synthesis, and anti-inflammatory processes.

Cycle 8-12 weeks

Tissue regeneration with enhanced skin and collagen benefits

Cycle 8-12 weeks

Potent GHRP with moderate appetite effects - balance between GHRP-6 and Ipamorelin. GHRP-2 offers strong GH release with less hunger increase than GHRP-6 and more potency than Ipamorelin, making it a versatile middle-ground option.

Cycle 8-12 weeks

Classic potent GH combination with GHRP-2's strong release

Cycle 8-12 weeks

Classic GHRP with strong appetite stimulation - good for bulking phases. GHRP-6 was one of the first growth hormone releasing peptides developed. It causes significant ghrelin release, resulting in substantial appetite increase, making it ideal for those struggling to eat enough.

Cycle 8-12 weeks

Glutathione is the master antioxidant tripeptide (γ-L-glutamyl-L-cysteinyl-glycine) that supports cellular detoxification, reduces oxidative stress, and maintains redox balance throughout the body. As the most abundant intracellular thiol, it plays a central role in neutralizing free radicals and supporting liver function.

Cycle Ongoing or 8-12 weeks

Bioidentical GnRH for maintaining fertility and natural hormone production during TRT

Cycle Ongoing during TRT or PCT

Comprehensive gut healing and microbiome support

Cycle 6-12 weeks

LH analog for testicular function, fertility, and testosterone support during TRT

Cycle Ongoing during TRT

Complete fertility and testicular function support for TRT users

Cycle Ongoing during TRT

The ultimate tissue repair stack combining BPC-157 (gut-brain-tissue healing), TB-500 (systemic wound healing and flexibility), and GHK-Cu (copper peptide for skin/collagen). This triple combination accelerates healing from injuries, surgeries, and chronic conditions through complementary regenerative mechanisms.

Cycle 6-12 weeks

Most potent GHRP with cardiac protective benefits but causes desensitization. Hexarelin is the strongest growth hormone releasing peptide available, producing the highest GH release of any GHRP. However, it causes receptor desensitization and should be cycled.

Cycle 4-8 weeks max (desensitization)

HGH 191AA is recombinant human growth hormone (somatropin) identical to endogenous GH secreted by the pituitary. It's the gold standard for GH replacement, studied extensively for effects on body composition, metabolism, tissue repair, and anti-aging. Clinical plans use subcutaneous administration once daily to mimic physiological GH secretion patterns.

Cycle 8-16 weeks or ongoing

Fat-burning fragment of HGH - targets adipose tissue specifically. This is the original, unmodified C-terminal fragment of human growth hormone that retains the fat-burning properties without the growth-promoting or blood sugar effects.

Cycle 8-12 weeks

Human menopausal gonadotropin containing both FSH and LH. Used to support spermatogenesis and ovarian stimulation in fertility plans.

Cycle Per medical plan

Humanin is a 24-amino acid mitochondrial-derived peptide (MDP) encoded in the mitochondrial genome. It was discovered in 2001 in the brain tissue of Alzheimer's patients. Humanin exhibits cytoprotective, anti-apoptotic, and metabolic-regulating properties, making it a promising peptide for longevity and neuroprotection research.

Cycle 8-12 weeks

Long-acting IGF-1 with extended half-life for muscle growth and recovery

Cycle 4-6 weeks on, 4 weeks off

Truncated IGF-1 analog lacking the first three amino acids, making it more potent and less bound by IGF binding proteins. Often used for localized muscle signaling via site-specific micro-injections.

Cycle 2-4 weeks on, 2-4 weeks off

Comprehensive immune enhancement for infections and prevention

Cycle 4-8 weeks as needed

Ipamorelin is the cleanest and most selective growth hormone releasing peptide (GHRP). Unlike other GHRPs, it does not significantly elevate cortisol, prolactin, or ghrelin levels, making it ideal for long-term use. It stimulates the pituitary to release growth hormone in natural pulsatile patterns.

Cycle 8-16 weeks, can run indefinitely

This blend combines tesamorelin, a synthetic GHRH analog, with ipamorelin, a selective ghrelin mimetic. When administered together, GHRH analogs and ghrelin mimetics produce synergistic GH pulses. Tesamorelin is FDA-approved for visceral fat reduction.

Cycle 12-26 weeks

Joint and cartilage repair with GH support for collagen synthesis

Cycle 8-12 weeks

GnRH stimulator for pulsatile LH/FSH release and natural testosterone boost

Cycle 4-8 weeks

Natural hormone axis support through GnRH and upstream stimulation

Cycle Ongoing or as needed

Multi-peptide blend combining TB-500 (10mg), BPC-157 (10mg), KPV (10mg), and GHK-Cu (50mg) for comprehensive tissue repair, anti-inflammatory, and regenerative support.

Cycle 8-16 weeks

Anti-inflammatory tripeptide derived from alpha-MSH for gut healing and inflammation control. KPV is the C-terminal fragment of alpha-melanocyte stimulating hormone (α-MSH) with potent anti-inflammatory properties. It inhibits NF-κB, reducing inflammation without immunosuppression.

Cycle 4-12 weeks

Amino acid derivative essential for fatty acid transport into mitochondria for beta-oxidation. Often used as an injectable for enhanced bioavailability alongside diet and exercise programs.

Cycle 8-12 weeks

Larazotide acetate (AT-1001) is an 8-amino acid synthetic peptide that regulates intestinal tight junctions. Originally developed for celiac disease, it prevents zonulin-induced intestinal permeability (leaky gut). It works locally in the gut and is not systemically absorbed, making it very safe.

Cycle 8-12 weeks or as needed

Daily GLP-1 agonist for weight management (Saxenda/Victoza)

Cycle Ongoing

Livagen is a tetrapeptide bioregulator (Lys-Glu-Asp-Ala) from the Khavinson series that specifically targets liver tissue. It supports hepatocyte function, liver regeneration, and protection against age-related liver decline and damage.

Cycle 10-20 days, repeat 2-3x yearly

Human antimicrobial peptide for immune defense against bacteria, viruses, and biofilms. LL-37 is the only human cathelicidin antimicrobial peptide (AMP) and plays a critical role in innate immunity. It directly kills pathogens and disrupts biofilms that protect chronic infections.

Cycle 2-4 weeks as needed

Ultimate anti-aging stack targeting multiple longevity pathways

Cycle Epitalon 10-20 day cycles, others 12 weeks

Collagen-boosting peptide complex (Pal-GHK + Pal-GQPR) for skin firmness

Cycle Ongoing

Mazdutide (IBI362) is a long-acting dual GLP-1/glucagon receptor agonist developed for chronic weight management and type 2 diabetes. Phase 2 and 3 clinical trials have demonstrated substantial weight loss (6-14% reduction over 24-48 weeks) with mostly mild gastrointestinal side effects.

Cycle Ongoing

Linear analog of alpha-melanocyte-stimulating hormone (α-MSH) that selectively activates MC1R receptors for melanogenesis. Studied for photoprotection and tanning without the broader melanocortin effects of Melanotan II.

Cycle 4-8 weeks

Synthetic melanotropin for skin pigmentation with libido and appetite effects

Cycle Loading 2-3 weeks, then maintenance

A melanocortin receptor stack combining Melanotan II (tanning and libido) with PT-141/Bremelanotide (sexual function). Both act on melanocortin receptors but PT-141 is more selective for sexual effects while MT-II also provides tanning benefits.

Cycle 4-8 weeks (tanning) | PT-141 as needed

A combination stack using Melanotan II for tanning and libido effects with PT-141 (Bremelanotide) for targeted sexual enhancement. Both work on melanocortin receptors but can be used together for comprehensive effects.

Cycle MT2: 4-6 weeks loading. PT-141: as needed

Tanning with enhanced libido/arousal effects

Cycle As needed

Injectable form of the pineal hormone melatonin for sleep regulation and circadian rhythm optimization. Higher bioavailability than oral supplements.

Cycle As needed

Complete metabolic enhancement for insulin sensitivity and fat loss

Cycle 12 weeks

Splice variant of IGF-1 for localized muscle repair and satellite cell activation

Cycle 4-6 weeks

Oral non-peptide GH secretagogue with 24-hour half-life. Increases IGF-1 significantly. MK-677 mimics ghrelin and binds to ghrelin receptors in the brain, stimulating the pituitary to release growth hormone in a sustained manner without affecting cortisol levels.

Cycle 12-24 weeks or longer

Mitochondrial peptide for metabolic regulation, exercise capacity, and insulin sensitivity. MOTS-c is a mitochondrial-derived peptide (MDP) that acts as an exercise mimetic, improving glucose metabolism and insulin sensitivity. It's particularly promising for metabolic syndrome and age-related metabolic decline.

Cycle 8-12 weeks

Dual mitochondrial support for cellular energy and metabolic health

Cycle 8-12 weeks

A comprehensive growth hormone optimization stack combining CJC-1295 DAC (weekly GHRH), Ipamorelin (daily GHRP), and MK-677 (daily oral GH secretagogue). This triple-combination maximizes endogenous GH production through multiple pathways for enhanced muscle growth, recovery, and body composition.

Cycle 12-24 weeks

Maximum muscle growth through GH and growth factor pathways

Cycle IGF 4-6 weeks, others 12-16 weeks

Acetylated Selank with enhanced bioavailability and stability. The N-Acetyl modification improves blood-brain barrier penetration and extends duration of action.

Cycle 2-3 weeks on, 1 week off

Acetylated Semax with improved potency and brain penetration. The N-Acetyl modification provides enhanced BDNF elevation and longer-lasting cognitive effects.

Cycle 2-3 weeks on, 1 week off

Enhanced bioavailability nootropic blend with acetylated versions

Cycle 2-3 weeks on, 1 week off

NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme involved in cellular energy metabolism, DNA repair, and mitochondrial function. Subcutaneous administration at lower doses is emerging as a practical maintenance route compared to high-dose IV infusions.

Cycle Ongoing or 8-12 weeks

Experimental small molecule that stimulates hippocampal neurogenesis. Developed for major depressive disorder, it promotes the growth of new neurons in the hippocampus, the brain region critical for memory and mood.

Cycle 8-12 weeks

Neuropeptides produced by lateral hypothalamic neurons that regulate wakefulness, appetite, and energy balance. Orexin signaling stabilizes the sleep-wake cycle and maintains alertness. Deficiency causes narcolepsy.

Cycle Investigational

Ovagen is a tripeptide bioregulator (Glu-Asp-Leu) from the Khavinson series that targets the liver and gastrointestinal tract. It supports digestive function, liver health, and the hepatobiliary system.

Cycle 10-20 days, repeat 2-3x yearly

Oxytocin is a nonapeptide hormone known as the 'bonding hormone' or 'love hormone'. While best known for roles in childbirth and lactation, it also influences social bonding, trust, anxiety reduction, and metabolic function. Research explores its effects on social cognition, stress reduction, appetite regulation, and pain modulation.

Cycle 8-16 weeks

Post-cycle therapy for HPTA recovery

Cycle 4-6 weeks

Spadin analog that blocks TREK-1 potassium channels for rapid antidepressant effects. PE-22-28 works through a novel mechanism distinct from traditional antidepressants, showing rapid onset of action in research studies.

Cycle 4-8 weeks

PEGylated MGF with extended half-life for systemic muscle repair

Cycle 4-6 weeks

Pentosan Polysulfate Sodium (PPS) is a semi-synthetic heparin-like glycosaminoglycan used for interstitial cystitis and osteoarthritis. It protects and repairs cartilage, replenishes the bladder's glycosaminoglycan layer, and has anti-inflammatory properties. Available as oral (Elmiron) or injectable forms.

Cycle 3-6 months for joint health

Pinealon is a tripeptide bioregulator (Glu-Asp-Arg) from the Khavinson series that targets the pineal gland and central nervous system. It supports melatonin production, circadian rhythm regulation, and brain function.

Cycle 10-20 days, repeat 2-3x yearly

PNC-27 is a synthetic peptide containing a p53 protein fragment linked to a cell-penetrating sequence. It selectively targets cancer cells that overexpress HDM-2 (a p53 inhibitor), inducing membrane lysis in cancer cells while leaving normal cells unaffected.

Cycle Research plans only

Accelerated surgical recovery with immune support

Cycle 4-8 weeks post-surgery

Prostamax is a peptide bioregulator from the Khavinson series that specifically targets prostate tissue. It supports prostate health, helps normalize prostate function, and may help with benign prostatic hyperplasia (BPH) and age-related prostate issues.

Cycle 10-20 days, repeat 2-3x yearly

Melanocortin receptor agonist for sexual dysfunction - works on desire/arousal pathway

Cycle As needed

A comprehensive athletic recovery stack combining healing peptides (BPC-157, TB-500) with a growth hormone secretagogue (Ipamorelin). This stack accelerates recovery from training, injuries, and supports tissue repair while enhancing GH-mediated recovery during sleep.

Cycle 8-12 weeks

Triple agonist (GLP-1/GIP/Glucagon) representing the next generation of weight loss peptides. Retatrutide activates three hormone pathways for potentially maximum weight loss efficacy, showing up to 24% body weight reduction in phase 2 trials.

Cycle Ongoing (maintenance)

Anxiolytic peptide derived from tuftsin for anxiety reduction and cognitive support. Selank is approved in Russia for anxiety and neurasthenia. It modulates GABA and serotonin without causing sedation, making it ideal for reducing anxiety while maintaining cognitive function.

Cycle 2-3 weeks on, 1 week off

GLP-1 receptor agonist for weight management and blood sugar control. The active ingredient in Ozempic and Wegovy, semaglutide mimics the GLP-1 hormone that regulates appetite, slows gastric emptying, and improves insulin sensitivity.

Cycle Ongoing (maintenance)

Russian nootropic peptide derived from ACTH (4-10) for focus, memory, and neuroprotection. Developed in Russia and approved for medical use there, Semax increases BDNF, enhances attention, and provides significant cognitive enhancement without stimulant side effects.

Cycle 2-3 weeks on, 1 week off

Comprehensive nootropic blend for focus and anxiety balance

Cycle 2-3 weeks on, 1 week off

Bioidentical GHRH (1-29) for natural GH stimulation - often prescribed by clinics. Sermorelin is identical to the first 29 amino acids of natural GHRH and was the first GHRH analog approved by the FDA. It stimulates the pituitary to produce and release growth hormone naturally.

Cycle 3-6 months typical

Dual GH pathway stimulation with clinic-approved Sermorelin

Cycle 12-24 weeks

Comprehensive sexual function and hormone support

Cycle Ongoing as needed

Deep sleep optimization with GH and melatonin support

Cycle DSIP 2-3 weeks, Epitalon 10-20 days, Ipa ongoing

SLU-PP-332 is a small molecule ERRα (estrogen-related receptor alpha) agonist that enhances mitochondrial function and endurance without exercise. It activates the same pathways as endurance training, increasing oxidative muscle fibers and exercise capacity.

Cycle Research plans

Acetyl octapeptide analog of SNAP-25 that competes for binding to vesicle-associated membrane protein (VAMP), destabilizing the SNARE complex and inhibiting acetylcholine release, thus reducing muscle contractions and wrinkles. A topical Botox alternative.

Cycle Ongoing

Aggressive sports injury recovery stack

Cycle 6-12 weeks

SS-31 (Elamipretide/Bendavia) is a mitochondria-targeted tetrapeptide that binds to cardiolipin in the inner mitochondrial membrane. It optimizes mitochondrial function, reduces oxidative stress, and has potential applications in aging, heart failure, and mitochondrial diseases.

Cycle 4-12 weeks or ongoing

Comprehensive stress and anxiety management stack

Cycle 2-4 weeks on, 1 week off

Survodutide (BI 456906) is an investigational dual GLP-1/glucagon receptor agonist under development for obesity and metabolic liver disease. In phase 2 trials, once-weekly dosing produced dose-dependent weight loss of 12.5-14.9% versus placebo over 46 weeks.

Cycle Ongoing

Experimental wound/skin repair peptide studied for tissue regeneration and skin healing applications. Limited published literature.

Cycle Short cycles

TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide that plays a crucial role in tissue repair, cell migration, and wound healing. It promotes systemic healing by upregulating actin production, stimulating angiogenesis, and reducing inflammation throughout the body.

Cycle 4-8 weeks loading, then maintenance

The foundational healing peptide stack combining TB-500 (systemic wound healing) with BPC-157 (localized tissue repair). This synergistic duo is the most popular combination for injury recovery, addressing healing through complementary mechanisms: systemic repair (TB-500) and targeted tissue healing (BPC-157).

Cycle 6-12 weeks

Targeted tendon and ligament repair stack

Cycle 8-16 weeks depending on injury

FDA-approved GHRH for HIV lipodystrophy - potent for visceral fat reduction. Tesamorelin (Egrifta) is the only FDA-approved treatment specifically for reducing visceral adipose tissue. It's a modified GHRH analog with enhanced stability and potency.

Cycle 12-26 weeks

FDA-grade GHRH with clean GHRP for visceral fat targeting

Cycle 12-24 weeks

Tesofensine is a triple reuptake inhibitor (serotonin, norepinephrine, dopamine) originally developed for Parkinson's and Alzheimer's. It was found to cause significant weight loss by reducing appetite and increasing satiety. It's now being developed specifically for obesity.

Cycle 12-24 weeks

Thymalin is a polypeptide complex extracted from calf thymus glands, developed in Russia for immune system restoration. It's one of the original peptide bioregulators studied by Professor Vladimir Khavinson. Thymalin restores thymic function, modulates T-cell immunity, and has demonstrated anti-aging properties in clinical studies.

Cycle 5-10 days, repeat 2-4x yearly

Immune modulating peptide for enhanced T-cell function and infection resistance. Thymosin Alpha-1 (TA1) is a naturally occurring thymic peptide that is FDA-approved in over 35 countries under the brand name Zadaxin for hepatitis B/C and as a vaccine adjuvant. It modulates T-cell function without overstimulating the immune system.

Cycle 8-12 weeks or as needed

Comprehensive immune support with T-cell and antimicrobial action

Cycle 4-8 weeks as needed

Dual GIP/GLP-1 receptor agonist for enhanced weight loss. The active ingredient in Mounjaro and Zepbound, tirzepatide activates both GIP and GLP-1 receptors for superior metabolic effects compared to single-agonist medications.

Cycle Ongoing (maintenance)

45mg blend for coordinated inflammation control, recovery, and healing

Cycle 4-8 weeks

Synthetic GnRH agonist that initially stimulates then suppresses LH/FSH, reducing testosterone/estrogen production. Used in PCT plans and medically for prostate cancer, endometriosis, and precocious puberty.

Cycle Single dose or medical plan

Complete fertility and natural production maintenance during TRT

Cycle Ongoing during TRT

BPC-157 + TB-500 + GHK-Cu comprehensive healing routine

Cycle 6-12 weeks

Vasoprotective tripeptide (Lys-Glu-Asp) derived from cattle vascular tissue. Stimulates neuronal differentiation, increases dendritic spine density, and has been shown to improve cognitive functions in neurodegenerative models.

Cycle 4-8 weeks

Vilon is a dipeptide bioregulator (Lys-Glu) from the Khavinson series that targets the immune system, particularly thymus function. It's one of the simplest bioregulators and supports immune cell development and function.

Cycle 10-20 days, repeat 2-3x yearly

Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuropeptide with potent anti-inflammatory and immunomodulatory properties. It's used in CIRS (Chronic Inflammatory Response Syndrome) plans for mold illness and is known for regulating cytokines, supporting pulmonary function, and modulating the immune response.

Cycle 4-12 weeks or longer for CIRS

Active cobalamin form for deficiency correction, nerve support, and methylation. Injectable form provides superior bioavailability compared to oral supplements.

Cycle Ongoing maintenance

GLP-1 agonist + fat-burning peptide for maximum weight loss

Cycle 12-24 weeks